Inside this portfolio
Identified stock classes44
Matched (%)99.16%
| Largest reported stocks | Portfolio weight |
|---|---|
| Eli Lilly & Co | 11.52% |
| UnitedHealth Group Inc | 5.24% |
| Novo Nordisk A/S | 5.24% |
| Roche Holding AG | 4.50% |
| Merck & Co Inc | 4.27% |
How to read these numbers
The day the fund recorded its holdings.
The share of the fund’s net assets that we could identify as common-stock classes.